Internal Medicine, Medical Oncology · Duarte, CA
NPI
1881793693
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 359-8111
Groups this clinician bills Medicare through
Medicare paid, 2023
$35K
1,281 services
Medicare patients, 2023
14
Average age 63
Drug cost, 2024
$6.6M
1,183 prescriptions
Company payments, 2025
$146
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Roberto Rodriguez prescribed most often to Medicare patients was Lenalidomide, with 211 prescriptions and refills. In total Roberto Rodriguez wrote 1,183 Medicare prescriptions that cost $6.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lenalidomide Generic | 211 | 211 | 22 | $2.0M |
| Dexamethasone Generic | 72 | 74 | 16 | $921 |
| Brukinsa Zanubrutinib | 67 | 67 | Under 11 | $766K |
| Alvaiz Eltrombopag Choline | 62 | 62 | Under 11 | $287K |
| Procrit Epoetin Alfa | 58 | 59 | Under 11 | $121K |
| Acyclovir Generic | 43 | 89 | 13 | $896 |
| Hydroxyurea Generic | 41 | 106 | 12 | $1,260 |
| Xarelto Rivaroxaban | 40 | 54 | Under 11 | $25K |
| Revlimid Lenalidomide | 37 | 37 | Under 11 | $689K |
| Imbruvica Ibrutinib | 33 | 33 | Under 11 | $464K |
| Imatinib Mesylate Generic | 30 | 30 | Under 11 | $1,506 |
| Hydrocortisone Generic | 26 | 30 | Under 11 | $733 |
| Temazepam Generic | 23 | 23 | Under 11 | $262 |
| Abiraterone Acetate Generic | 23 | 23 | Under 11 | $3,492 |
| Tamoxifen Citrate Generic | 22 | 67 | Under 11 | $566 |
Brand drugs: 468 claims; generic drugs: 715 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto Rodriguez $146 ($146 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $85.13.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.